Search research articles
Contact Us
Filters
Showing results (71-80 of 150) with videos related to
Page
of 15
Sort By:
Journal of Kidney Cancer and VHL
|
October 20, 2025
Meet-URO Score Validation in Real-world Patients with Metastatic Renal Cell Carcinoma Receiving First-line Pembrolizumab Plus axitinib: A Subanalysis of the Prospective ProPAXI Study
Giulia Airò, Annalisa Guida, Alessio Gili, et al.
Cancers
|
January 28, 2026
Long-Term Oncological Outcomes in Metastatic Prostate Cancer Patients Who Are Able to Maintain/Recover Ongoing Anticancer Therapy After SARS-CoV-2 Infection-Results of the MEET-URO 22 Study
Orazio Caffo, Umberto Basso, Antonello Veccia, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
July 15, 2016
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis
Nicola Veronese, Matteo Fassan, Laura D Wood, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 27, 2026
Multidisciplinary approach to bone metastases: a single center experience in a tertiary cancer center
Chiara Pittarello, Antonella Brunello, Evelina Lamberti, et al.
Targeted Oncology
|
June 25, 2022
Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study
Marco Maruzzo, Francesco Pierantoni, Alberto Bortolami, et al.
Scientific Reports
|
February 28, 2024
Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study
Lucia Fratino, Jerry Polesel, Emilio Francesco Giunta, et al.
Tumori
|
May 4, 2026
International multicenter experience of prognostic factors and treatment outcomes of metastatic non-clear cell renal cell carcinoma
Alessandro Rametta, Sebastiano Buti, Marco Stellato, et al.
European Urology Oncology
|
July 11, 2025
Evaluating Treatment Efficacy in Metastatic Hormone-sensitive Prostate Cancer Patients with Visceral Disease: A Systematic Review and Network Meta-analysis
Fabiano Flauto, Giuseppe Neola, Carmine Caso, et al.
Cancer Treatment and Research Communications
|
November 3, 2019
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study
Sebastiano Buti, Melissa Bersanelli, Alessandro Viansone, et al.
Clinical Genitourinary Cancer
|
January 22, 2017
First-Line PAzopanib in NOn-clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study
Sebastiano Buti, Melissa Bersanelli, Francesca Maines, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 150) with videos related to
Sort By:
Page
of 15
Journal of Kidney Cancer and VHL
|
October 20, 2025
Meet-URO Score Validation in Real-world Patients with Metastatic Renal Cell Carcinoma Receiving First-line Pembrolizumab Plus axitinib: A Subanalysis of the Prospective ProPAXI Study
Giulia Airò, Annalisa Guida, Alessio Gili, et al.
Cancers
|
January 28, 2026
Long-Term Oncological Outcomes in Metastatic Prostate Cancer Patients Who Are Able to Maintain/Recover Ongoing Anticancer Therapy After SARS-CoV-2 Infection-Results of the MEET-URO 22 Study
Orazio Caffo, Umberto Basso, Antonello Veccia, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
July 15, 2016
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis
Nicola Veronese, Matteo Fassan, Laura D Wood, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 27, 2026
Multidisciplinary approach to bone metastases: a single center experience in a tertiary cancer center
Chiara Pittarello, Antonella Brunello, Evelina Lamberti, et al.
Targeted Oncology
|
June 25, 2022
Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study
Marco Maruzzo, Francesco Pierantoni, Alberto Bortolami, et al.
Scientific Reports
|
February 28, 2024
Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study
Lucia Fratino, Jerry Polesel, Emilio Francesco Giunta, et al.
Tumori
|
May 4, 2026
International multicenter experience of prognostic factors and treatment outcomes of metastatic non-clear cell renal cell carcinoma
Alessandro Rametta, Sebastiano Buti, Marco Stellato, et al.
European Urology Oncology
|
July 11, 2025
Evaluating Treatment Efficacy in Metastatic Hormone-sensitive Prostate Cancer Patients with Visceral Disease: A Systematic Review and Network Meta-analysis
Fabiano Flauto, Giuseppe Neola, Carmine Caso, et al.
Cancer Treatment and Research Communications
|
November 3, 2019
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study
Sebastiano Buti, Melissa Bersanelli, Alessandro Viansone, et al.
Clinical Genitourinary Cancer
|
January 22, 2017
First-Line PAzopanib in NOn-clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study
Sebastiano Buti, Melissa Bersanelli, Francesca Maines, et al.
Page
of 15